None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All newborns (less than 10 days of life) irrespective of the age of gestation, parity, mode of delivery, mode of feeding who have jaundice that seem significant to the naked eye. (Krammer zone 3 and beyond) Newborns with jaundice who have not received any treatment in the form of exchange blood transfusion. Newborns receiving phototherapy with a photo opaque heat reflective patch over the area of the forehead, and sternum where TCB measurement will be taken from.
Exclusion criteria
Exclusion criteria: Neonates whose age is more than 10 days of life. Neonates who needed exchange transfusion. When a serum value is not available. Severe multiple anomalies. Patients with known liver disease, conjugated hyperbilirubinemia, or metabolic disorders that affect bilirubin metabolism. Those who had culture-proven sepsis. Unwillingness to participate or refusal of consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The findings of this study will have implications for clinical practice in managing neonatal jaundice. If TcB measurements are found to be accurate and reliable, they could replace serum bilirubin measurements in some settings, reducing the need for invasive procedures and improving the care of newborns with jaundice Timepoint: at baseline, 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Sir H. N. Reliance Foundation Hospital and Research Centre